Stay updated on Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.

Latest updates to the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdds a 2015 (U.S. NIH Grant/Contract) funding line and updates the site revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the study record documentation.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision tag updated to v3.6.4, indicating the current build of the page. It replaces the previous v3.6.3.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a small patch or update to the page template or internal documentation. This appears to be an incremental improvement rather than a substantive content modification.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page's underlying software version was updated from v3.6.0 to v3.6.2, indicating a patch-level release.SummaryDifference0.0%

- Check98 days agoChange DetectedThe page now shows recruitment has ended and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) to aid user navigation. It also reflects a minor header formatting change to Intervention/Treatment and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.1%

Stay in the know with updates to Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.